SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?


To: michael_f_murphy who wrote (76)3/5/2000 5:00:00 PM
From: Jongmans  Read Replies (2) | Respond to of 625
 
Comparing market valuations of Human Monoclonal Antibody companies (MEDX, ABGX, CAT and MorphoSys}, Europeans Cambridge Antibody Technology and MorphoSys, but in particular the first, are still at an extremely low valuation level. There is no basic reason for that. For all, being post-genomics- the future is bright.

martin